Claire Y Huang

Title: Claire Y Huang: Innovator in Dengue Virus Research

Introduction

Claire Y Huang is a prominent inventor based in Fort Collins, Colorado. She has made significant contributions to the field of virology, particularly in the development of vaccine compositions for dengue virus serotype-4. Her innovative work aims to enhance immune responses against this viral infection.

Latest Patents

Claire Y Huang holds a patent for "Compositions, methods and uses for dengue virus serotype-4 constructs." This patent details compositions that include DENV-4 virus constructs, which can be utilized in vaccine formulations to induce an immune response in subjects. The patent also discusses the potential for combining DENV-4 constructs with other serotypes of dengue virus, such as dengue-1, dengue-2, and dengue-3, as well as other flavivirus constructs to create a multi-target vaccine. The methods outlined in her patent demonstrate improved immune responses when modified constructs are used compared to traditional vaccine compositions.

Career Highlights

Throughout her career, Claire has worked with notable organizations, including Takeda Vaccines, Inc. and the National Institutes of Health, which is a component of the US Department of Health & Human Services. Her experience in these institutions has allowed her to contribute to significant advancements in vaccine research and development.

Collaborations

Claire has collaborated with esteemed colleagues, including Jill Ann Livengood and Timothy D Powell. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her research endeavors.

Conclusion

Claire Y Huang is a dedicated inventor whose work in dengue virus research has the potential to impact public health positively. Her innovative approaches to vaccine development highlight her commitment to advancing medical science.